Christopher McQuinn

IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer

Thomas A. Mace, Reena Shakya, Jason R. Pitarresi et al. · Gut · 2016 · 546 citations · Full text

Life Sciences, Immunology, Oncology +17

A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186

Cameron J. Herting, Matthew R. Farren, Yan Tong et al. · Cancer Immunology Immunotherapy · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacology +11

Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell– and CXCR3-dependent manner

Michael B. Ware, Maggie Phillips, Christopher McQuinn et al. · JCI Insight · 2023 · 37 citations · Full text

Medicine, Immunology, Oncology +17

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Casey R. Ager, Matthew J. Reilley, Courtney Nicholas et al. · Journal for ImmunoTherapy of Cancer · 2016 · 17 citations · Full text

Medicine, Immunology, Oncology +17

Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer

Robert Wesolowski, Andrew Stiff, Dionisia Quiroga et al. · BMC Cancer · 2020 · 16 citations · Full text

Life Sciences, Immunology, Oncology +17